{
    "2021-06-21": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Novartis Touts More Positive Zolgensma Data In Spinal Muscular Atrophy Patients",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Zolgensma",
                        "Positive Data",
                        "Spinal Muscular Atrophy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}